PKD1 and prostate carcinoma: Although phosphorylation of E-cadherin by PKD1 is reportedly associated with increased cellular aggregation and decreased cellular motility in prostate cancer [20], our result is consistent with the demonstration that E-cadherin tyrosine-phosphorylation status contributes to its ubiquitination and subsequent increase in cell migration [21].